In this "sandwich"-type enzyme immunoassay of galactosyltransferase isoenzyme II (GT-II), we used the monoclonal antibody MAb 3872 previously established and charactenzed to be specific for GT-II. Plastic beads coated with MAb 3872 were incubated with serum and buffer, washed, then incubated with MAb 3872 conjugated with horseradish peroxidase and again washed. Peroxidase activity remaining on the beads was measured by color development with ophenylenediamine. The assay standard curve was linear from 0 to 150 kU/L. Inter-and intra-assay CVs were <9% and <7%, respectively. Mean GT-ll values for 370 normal controls were 6.8 (SD 3.4) kU/L with no significant sex-, smoking-, or blood-type-related differences. We also assayed serum from patients with 11 different cancers or with matched benign diseases. The diagnostic sensitivity of GT-II for liver and esophageal cancer was 0.91 and 0.72, respectively, apparently higher than for carcinoembryonic antigen (CEA) or a-fetoprotein. GT-ll and CEA concentrations in sera were not correlated. Evidently this assay may be useful as a cancer diagnostic test to supplement existing serological methods.
improved methods, not only for characterizing tumor markers but also for quantifring specific tumor markers in serum (4).
We previously reported the preparation of the monoclonal antibody (MAb 3872) against galactosyltransferase isoenzyme II (EC 2.4.1.38) and the characterization of GT-H (5, 6). In the preliminary studies, we determined the concentrations of GT-II in serum by a method based on measuring GT enzyme activity bound to MAb 3872, but that assay was too tedious and inaccurate for routine clinical application.
We describe here a "sandwich"-type enzyme imniunoassay (EIA) for GT-ll, including specifications for the assay and our clinical evaluation of it as a tumor marker.
MaterIals and Methods

Preparation of Immunoreagents
Murine hybridoma 3872 cells were cloned, grown in tissue culture (RPMI-b640 containing fetal calf serum, 100 mLIL), and used to prepare ascitic fluid in Balb/c mice primed with pristane (Aldrich Chemical Co., Milwaukee, WI 53233). MAb 3872 (IgG1) was purified by precipitation with 50%-saturated ammonium sulfate from ascites, "Fast Protein Liquid Chromatography" with S-Sepharose and Q-Sepharose (Pharmacia AB, Uppsala, Sweden), and saltgradient elution. Purified MAb 3872 was immobilized on 6-mm-diameter ABS no.80 resin beads (Sekisui Chemical Co., Tokyo, Japan). The beads were exposed to a 10 pg/mL solution of MAb 3872 in carbonate buffer (0.2 mol/L, pH 9.5) at 4#{176}C overnight, with shaking. After washing the beads three times with phosphate-buffered saline (PBS) and blocking any uncoated sites remaining with PBS containing 10 g of bovine serum albumin per liter (PBS! BSA), we stored them at 4#{176}C in PBS/BSA containing 1 g of sodium azide per liter. We conjugated MAb 3872 with horseradish peroxidase (HRP; EC 1.11.1.7), using the periodate method (7). Assay standards were prepared from partly purified antigen that had been fractionated by gel ifitration of ascitic fluids from patients with ovarian tumor.
The concentration of GT-II in serum was determined from standard curves and expressed in arbitrary units (kUfL).
Assay Protocol
The principle of the assay was "forward sandwich enzyme immunoassay." We added the assay components to each well of a reaction tray in the following order: 50 p.L of serum sample, 200 1zLof pH 9.5 buffer (per liter, 0.1 mol of carbonate and 0.15 mol of NaC1), and an immobilized-MAb bead. After they were incubated at room temperature overnight, the beads were washed three times with PBS, incubated with 200 L of HRP conjugate in PBS/BSA for 2 h at room temperature, then washed four times with PBS. 
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GT-II Concentrations In Sera from 370 Normal indIvIduals
We transferred the still-wet beads into test tubes, followed by 500 L of pH 5.0 developing buffer (0.1 moIJL citratephosphate containing 3 g of o-phenylenediamine and 0.3 g of hydrogen peroxide per liter). After 30 mm at room temperature, we stopped the reaction by adding 2 mL of a 0.5 moLIL solution of sulfuric acid and measured each sample's absorbance at 492 nm. The GT-fl concentrations were determined by using a calibration curve. CEA and APP were assayed (EIA) according to the protocols suggested by the supplier (Abbott Labs., North Chicago, IL 60064).
Serum Samples
We obtained patients' serum samples from the Japanese National Cancer Institute Serum Bank. The assay results were correlated with the clinical data from the Institute after blind examination. Normal control samples were collected from apparently healthy volunteers among Konica employees. These samples were stored at -40 #{176}C before use.
Usually, we tested a sample in duplicate and reported the mean value.
Results
The standard curve was linear for concentrations of GT-J1 ranging from 0 to 150 kUIL (Figure 1) . The sensitivity was calculated to be 1.5 kUIL, the GT-ll concentration corresponding to 2 SD of measurements for the 0 kUIL standard. Reproducibility (n = 25), inter-and intra-assay, were respectively <9% and <7%, indicating adequate precision over the entire range of the standard curve. Assay linearity was examined by assaying patients' serum samples diluted with pooled serum from normal controls. For dilution ratios of 1 to 16, observed GT-H values were within 90% to 110% of the expected (calculated) GT-H values (Table 1) .
GT-U values for 370 apparently healthy donors are shown in Figure 2 ; the mean was 6.8 (SD 3.4) kUIL. Use of the log of each value resulted in a good approximation to a normal distribution curve. The mean and SD of log i were 0.7800 and 0.2136; thus the mean plus 2 SD and plus 3 SD was 16.12 and 26,36 kUIL, respectively, after normalization. In this paper, the primary cutoff value was determined to be 20 kUfL, below which 99.5% of the values for apparently healthy donors fell. We saw no sex-, blood type-, or smoking-related effects on GT-ll values, but values for the older subjects were significantly (P <0.05) higher than for the younger subjects (Table 2) . 
No. posItIve/total no. (and 5)
On the other hand, values for all of 18 patients' sera with benign liver were <20 kU/L. As for liver cancer-hepato- GT is present in plasma membrane and Golgi apparatus of all tissues, where it synthesizes carbohydrate moieties, which are secreted into body fluids. Thus GT-il also probably is not organ-specific. Nevertheless, GT-H values for sara of patients with esophageal cancer showed the highest sensitivity, 0.91.
The need for a combination assay was suggested by the fact that the GT-il and CEA values were not correlated with each other. In fact, use of the combination assay of GT-fl and CEA for sera from patients with breast cancer increased the sensitivity from 0.50 for GT-il and 0.40 for CEA to 0.70 for the combination.
However, use of the combination assay also decreased the specificity from 0.85 for GT-il and 0.90 for CEA to 0.80 for the combination.
In summary, we developed and evaluated the GT-H EIA as a useful method for diagnosis of liver cancer and esophageal cancer. More detailed examination, including the correlation of the GT-il value change with clinical response, is needed.
